Active-ingredient Dossier
Hydrocortisone
Active-ingredient Dossier for Hydrocortisone (corticosteroid). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: HYDROCORTISONE VIATRIS
- Brand: HYSONE
- Brand: ALKINDI
- Brand: EGOCORT
- Brand: APOHEALTH
- Brand: CANDACORT
- Therapeutic area: Dermatology
- Therapeutic area: Endocrinology
- Therapeutic area: Gastroenterology
What is Hydrocortisone Hydrocortisone is a corticosteroid .
Australian brands containing
Hydrocortisone — HYDROCORTISONE VIATRIS — ALKINDI — CANDADERM — CIPROXIN — EGOCORT — HYDROZOLE — HYSONE
Therapeutic areas
Hydrocortisone is registered across multiple therapeutic areas: Dermatology (5 brands), Endocrinology (4 brands), Gastroenterology (2 brands), Infectious Disease (2 brands), Complementary Medicine (1 brand), and Pain Management (1 brand) .
Sponsor landscape
Hydrocortisone is marketed by nine sponsors, including Nova Pharmaceuticals, AFT Pharmaceuticals, Ego Pharmaceuticals, Alphapharm, Chiesi, and Novartis Pharmaceuticals .
PBS and regulatory activity
One brand containing hydrocortisone has PBS-listed items, with the latest PBS schedule date of 1 May 2026 . The latest PBAC outcome on record is from 1 September 2023, with one brand having a PBAC outcome recorded and no brands with AusPARs on record .